UCR campus closed.

Spring 2020 Quarter Held Online. COVID-19 Updates

Breadcrumb

US Patent Awarded for Osmotic Transport Device

Device will be used to treat edema (tissue swelling) for severe TBI and stroke patients
By V. G. J. Rodgers |

Professors Rodgers, Park and Binder (in the School of Medicine) and associates are inventors for US Patent No. 10420918 B2 dated September 24, 2019 for a membrane osmotic transport device (OTD). The OTD can gently remove fluid due to swelling of exposed tissue of the brain or other areas of the nervous system that resulted from traumatic injury. The patent entitled "Compositions and methods for reducing traumatic edema of the central nervous system" has the potential to reduce edema for patients with some of the most severe injuries that require craniectomy. The researchers hope the device will one day be a significant tool for helping patients with such injuries.